Skip to main content

Table 1 Participant Demographics (Safety Population)

From: Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day

    

LDX Dose

Category

 

Age Group

Statistic

30 mg/d

50 mg/d

70 mg/d

All doses

Age (y)

 

6-9

n

27

15

6

48

   

Mean (SD)

8.5 (0.75)

8.5 (0.74)

8.0 (0.89)

8.5 (0.77)

  

10-12

n

31

35

15

81

   

Mean (SD)

10.9 (0.96)

10.9 (0.73)

11.4 (1.12)

11.0 (0.91)

Sex*

Male

6-9

n (%)

18 (66.7)

13 (86.7)

6 (100)

37 (77.1)

 

Female

 

n (%)

9 (33.3)

2 (13.3)

0

11 (22.9)

 

Male

10-12

n (%)

26 (83.9)

24 (68.6)

11 (73.3)

61 (75.3)

 

Female

 

n (%)

5 (16.1)

11 (31.4)

4 (26.7)

20 (24.7)

Weight (lb)

 

6-9

n

27

15

6

48

   

Mean (SD)

62.2 (8.78)

65.0 (13.75)

53.1 (2.50)

61.9 (10.62)

  

10-12

n

31

35

15

81

   

Mean (SD)

78.9 (16.36)

79.0 (18.64)

80.7 (17.29)

79.3 (17.34)

Height (in)

 

6-9

n

27

15

6

48

   

Mean (SD)

51.2 (2.30)

52.1 (2.29)

49.3 (2.04)

51.3 (2.38)

  

10-12

n

31

35

15

81

   

Mean (SD)

56.2 (2.84)

56.2 (3.08)

57.3 (2.79)

56.4 (2.93)

Body mass index (kg/m2)

 

6-9

n

27

15

6

48

   

Mean (SD)

16.6 (1.44)

16.7 (2.38)

15.4 (1.28)

16.5 (1.78)

  

10-12

n

31

35

15

81

   

Mean (SD)

17.4 (2.45)

17.4 (2.67)

17.2 (2.55)

17.4 (2.53)

  1. SD: standard deviation.
  2. *Percentages are based on number of participants in the age group of the dose classification.